MarketPeel
Insider Trading Intelligence
Pricing
…
TH

Theresa Heggie

BCRX
DIRECTOR · BIOCRYST PHARMACEUTICALS INC · CIK 0001760020
FILING MIX · LIFETIME85%/15%
BUYS
33
SELLS
6
TOTAL VALUE
$1.88M
COMPANIES
1
ACTIVE SINCE
Mar 2020
HOLDINGS NOW
80,646
AVG SELL PX
$9.02
TRADE KIND
SHOWING 39 / 39
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 5 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Theresa Heggie, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+66.67%-0.51%-0.88%+0.37%-0.71%—
14d3+66.67%-2.32%+0.66%-2.98%-0.43%—
30d3+66.67%+1.28%+5.00%-3.72%-9.21%—
60d3+66.67%+0.96%+1.50%+3.70%+3.70%—
90d3+66.67%+0.78%+7.83%-7.05%-21.15%—
180d3(1 pending)+50.00%+0.62%+10.12%-9.49%-9.49%—
1y3(2 pending)+0.00%+68.07%+11.39%+56.68%+56.68%—
2y3(2 pending)+0.00%+41.01%+36.66%+4.35%+4.35%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BCRX · 80,646 shares · as of Jun 11, 2026
033,83867,676101,514135,352202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 33 buys / 6 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
15,294——80,646Jun 11, 2026Jun 15, 2026 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
33,540——33,540Jun 11, 2026Jun 15, 2026 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
49,933——0Mar 20, 2026Mar 24, 2026 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
49,933$10.11$504.8K65,352Mar 20, 2026Mar 24, 2026 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASE
49,933$6.30$314.6K115,285Mar 20, 2026Mar 24, 2026 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
30,000——0Aug 13, 2025Aug 15, 2025 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
40,000——0Aug 13, 2025Aug 15, 2025 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASE
30,000$2.91$87.3K95,352Aug 13, 2025Aug 15, 2025 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASE
40,000$5.41$216.4K135,352Aug 13, 2025Aug 15, 2025 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
70,000$8.51$595.9K65,352Aug 13, 2025Aug 15, 2025 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
12,500——65,352Jun 12, 2025Jun 16, 2025 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
27,181——27,181Jun 12, 2025Jun 16, 2025 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
6,698$6.11$40.9K52,852Jun 14, 2024Jun 14, 2024 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
6,820——59,550Jun 12, 2024Jun 14, 2024 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
49,933——49,933Jun 12, 2024Jun 14, 2024 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
870$6.46$5.6K52,730May 31, 2024Jun 3, 2024 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
999$5.63$5.6K51,860Feb 29, 2024Mar 4, 2024 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
956$5.88$5.6K50,861Nov 30, 2023Dec 1, 2023 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
791$7.11$5.6K49,905Aug 31, 2023Sep 5, 2023 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
39,072——39,072Jun 13, 2023Jun 15, 2023 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
16,745——49,114Jun 13, 2023Jun 15, 2023 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
680$8.27$5.6K32,369May 31, 2023Jun 2, 2023 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
635$8.85$5.6K31,689Feb 28, 2023Mar 2, 2023 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
421$13.36$5.6K31,054Nov 30, 2022Dec 2, 2022 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
404$13.90$5.6K30,633Aug 31, 2022Sep 2, 2022 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
12,866——30,229Jun 7, 2022Jun 9, 2022 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
30,022——30,022Jun 7, 2022Jun 9, 2022 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
1,138$9.31$10.6K17,363May 31, 2022Jun 2, 2022 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
602$16.61$10.0K16,225Feb 28, 2022Mar 2, 2022 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
829$12.06$10.0K15,623Nov 30, 2021Dec 2, 2021 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
628$15.92$10.0K14,794Aug 31, 2021Sep 2, 2021 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
317$15.77$5.0K14,166May 28, 2021Jun 1, 2021 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
40,000——40,000May 25, 2021May 27, 2021 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
463$10.78$5.0K13,849Feb 26, 2021Mar 2, 2021 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
978$5.11$5.0K13,386Nov 30, 2020Dec 2, 2020 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
1,204$4.15$5.0K12,408Aug 31, 2020Sep 2, 2020 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
1,112$4.50$5.0K11,204Jun 1, 2020Jun 3, 2020 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
40,000——40,000May 12, 2020May 14, 2020 ↗View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
1,666$3.00$5.0K10,092Mar 1, 2020Mar 3, 2020 ↗View →
Other insiders · BCRX
Loading peer insiders…
About this filer
CIK 0001760020
ROLE
Director
PRIMARY
BCRX
COMPANIES
1
ACTIVE SINCE
Mar 2020
MARKETPEEL · /INSIDER/0001760020DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback